Abstract
Antituberculosis therapy-associated cutaneous leukocytoclastic vasculitis (CLV) has been rarely reported. We describe a case of CLV induced by rifampicin and pyrazinamide. A 14-year-old male diagnosed with disseminated tuberculosis developed purpuric lesions after 1.5 months of treatment. Histopathology was consistent with leukocytoclastic vasculitis. Skin lesion improved after cessation of the two drugs and treatment with corticosteroids.
Original language | English |
---|---|
Article number | fmt048 |
Pages (from-to) | 507-508 |
Number of pages | 2 |
Journal | Journal of Tropical Pediatrics |
Volume | 59 |
Issue number | 6 |
DOIs | |
Publication status | Published - Dec 2013 |
Externally published | Yes |
Keywords
- Cutaneous leukocytoclastic vasculitis
- Pyrazinamide
- Rifampicin